Fundraising Fox
Chris Hollowood
InvestorChief Executive Officer of Syncona Investment Management Ltd. at Syncona
Find your path to Chris
32 people in our graph can introduce you to Chris.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Alessio D'addabbo to introduce you to Chris
You →Alessio · together at Syncona →Chris
Ask Jamie Chen to introduce you to Chris
You →Jamie · 11 people · together at Syncona →Chris
Sign up to find every way you can get introduced to Chris
- Your email: the people you already email who know Chris
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Chris
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Chris Hollowood is Chief Executive Officer of Syncona Investment Management Ltd., having joined Syncona at its 2012 launch and served as Chief Investment Officer until 2022. He has over 20 years of life science investment experience and has led the development of Syncona's gene therapy strategy, founding companies in ocular, hepatic, renal and central nervous system therapeutics. He previously worked at Apposite Capital LLP, Bioscience Managers Ltd, Neptune Investment Management Ltd and in the pharmaceutical industry, and holds a degree in Natural Sciences and a PhD in Organic Chemistry from the University of Cambridge.
Invests in
BiotechMedical Devices
Deals · 1
Gyroscope Therapeutics LtdBoard seat
via Syncona · filed Apr 2021 · $148M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
BeaconBeacon TherapeuticsGyroscopeNightstarPurespringPurespringSpurSpur TherapeuticsYellowstoneYellowstone Biosciences
Sources: the firm's website · SEC Form D filings.
Colleagues at Syncona
Frequently asked questions
- Who is Chris Hollowood?
- Chris Hollowood is Chief Executive Officer of Syncona Investment Management Ltd., having joined Syncona at its 2012 launch and served as Chief Investment Officer until 2022. He has over 20 years of life science investment experience and has led the development of Syncona's gene therapy strategy, founding companies in ocular, hepatic, renal and central nervous system therapeutics. He previously worked at Apposite Capital LLP, Bioscience Managers Ltd, Neptune Investment Management Ltd and in the pharmaceutical industry, and holds a degree in Natural Sciences and a PhD in Organic Chemistry from the University of Cambridge.
- Where does Chris Hollowood work?
- Chris Hollowood is Chief Executive Officer of Syncona Investment Management Ltd. at Syncona.
- What does Chris Hollowood invest in?
- Chris Hollowood invests in Biotech, Medical Devices.
- What boards does Chris Hollowood sit on?
- Chris Hollowood holds tracked board seats at Beacon, Beacon Therapeutics, Gyroscope, Gyroscope Therapeutics Ltd, Nightstar, Purespring, Purespring, Spur, Spur Therapeutics, Yellowstone.